98,446 Shares in Sotera Health Company $SHC Purchased by Ieq Capital LLC

Posted by on Aug 26th, 2026

Ieq Capital LLC acquired a new position in shares of Sotera Health Company (NASDAQ:SHC – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 98,446 shares of the company’s stock, valued at approximately $1,747,000.

A number of other large investors also recently added to or reduced their stakes in the business. CenterBook Partners LP boosted its stake in Sotera Health by 94.1% in the fourth quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after acquiring an additional 73,473 shares during the last quarter. Militia Capital Management LLC bought a new stake in shares of Sotera Health during the 1st quarter valued at $3,877,000. Geode Capital Management LLC lifted its stake in shares of Sotera Health by 13.8% in the 4th quarter. Geode Capital Management LLC now owns 3,931,834 shares of the company’s stock valued at $69,372,000 after purchasing an additional 476,365 shares during the period. Balefire LLC acquired a new position in shares of Sotera Health in the 1st quarter valued at $1,476,000. Finally, Bank of New York Mellon Corp lifted its stake in shares of Sotera Health by 13.4% in the 1st quarter. Bank of New York Mellon Corp now owns 1,403,971 shares of the company’s stock valued at $20,133,000 after purchasing an additional 166,055 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Price Performance

SHC opened at $19.51 on Wednesday. The stock has a market cap of $5.57 billion, a P/E ratio of 34.23 and a beta of 1.77. Sotera Health Company has a 12 month low of $13.09 and a 12 month high of $19.85. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The company has a fifty day simple moving average of $17.89 and a 200 day simple moving average of $16.36.

Sotera Health (NASDAQ:SHC – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same period in the previous year, the company posted $0.20 earnings per share. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, research analysts expect that Sotera Health Company will post 0.86 EPS for the current year.

Insider Activity

In related news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,294,515 shares of company stock worth $23,999,528 in the last quarter. 15.36% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on SHC shares. Citigroup lifted their price objective on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Weiss Ratings upgraded Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Piper Sandler restated an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. The Goldman Sachs Group began coverage on Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price target for the company. Finally, JPMorgan Chase & Co. increased their price target on shares of Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $21.50.

Read Our Latest Analysis on SHC

Sotera Health Profile

(Free Report)

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Read More

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.